# A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model

> **NCT00814944** · PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 143 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Sirolimus
- **DRUG:** Sirolimus
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00814944
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2013-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814944, "A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00814944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*